03/05/21 -"We have slightly raised our target price following what we judge as an encouraging Q1 21 trading update (please refer to our 26/04/2021 Latest). Going forward, vaccination, which has been strong in ..."
Pages
56
Language
English
Published on
03/05/21
You may also be interested by these reports :
16/10/26
The increase in the target price reflects the update of our model, with the main valuation change stemming from the NAV revision following the higher ...
13/10/26
Publicis delivered a solid Q3 2026, with organic net revenue growth accelerating to +5.0%, slightly ahead of consensus. Connected Media remained a ...
07/10/26
Last time we teased RELX (ADD; UK) in early January 2025, the stock was near its ATH, being recognised as a GenAI winner. The story changed abruptly ...
06/10/26
Informa has announced its intention to become a B2B Events pure player, triggering a process to divest its publishing arm, Taylor & Francis, and the ...